Neuroendocrine Prostate Cancer (NEPC) is a rare and clinically aggressive subtype of Prostate Cancer (PCa) with its own biological behavior, unfavorable prognosis, and resistance to androgen receptor (AR) directed therapies. This evidence concerns the gene AR and prostate cancer.